Clinical research in its early stages relates to clinical trials of drug development in its initial steps. Its importance is high, given that it allows patients to access innovative treatments and researchers the chance to gain experience in the development of medicines, said Spain’s trade group Farmaindustria in a web posting.
It is remarkable that we are experiencing a growing trend of this activity in Spain - reflected in the Guide of Clinical Research Units in Early Stages, presented by Farmaindustria in Valencia on Friday - a public event that brought together more than 200 representatives from the public and private sectors in biomedical research.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze